Anchor Drugs Pharmacy (Jajco Inc.), South San Francisco, CA
Is Anchor Drugs Pharmacy (Jajco Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Anchor Drugs Pharmacy (Jajco Inc.) hold a California pharmacy license?
No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones.
Has Anchor Drugs Pharmacy (Jajco Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Dec 6, 2019), 1 state referral letter (Dec 6, 2019) and 1 FMD-145 letter (Dec 6, 2019) for Anchor Drugs Pharmacy (Jajco Inc.). State board actions: no California State Board of Pharmacy action under this exact name and city was found in the board’s posted disciplinary decisions on facility licenses (actions dated Jan 5, 2005 to Oct 28, 2026) on Nov 6, 2026. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Jajco Inc.; Anchor Drugs Pharmacy
- Location
- South San Francisco, CA
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Dec 6, 2019
- FDA Data Dashboard inspections
- 2 inspections: 1 OAI, 1 VAI; 2 published Form 483s
- Form 483 text on this page
- 1 Form 483, 2 observations
- State board records
- No exact match
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Jajco Inc. (dba Anchor Drugs Pharmacy), a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Dec 6, 2019 | State referral letter | Referral Letter to the California State Board of Pharmacy Issued 12/06/2019 | FDA copy (archived) |
| Dec 6, 2019 | FMD-145 letter | FMD-145 Letter Issued 12/06/2019 | FDA copy (archived) |
| Dec 6, 2019 | Warning letter close-out | Warning Letter Close Out Issued 12/06/2019 | Not linked by FDA |
An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Jajco, Inc., South San Francisco, CA (FEI number 3012327563), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Oct 29, 2018 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3012327563 | 1070915 |
| Jun 3, 2016 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3012327563 | 974160 |
Form 483s FDA has published for this site
- Oct 29, 2018: Form 483 to Jajco, Inc., published Apr 30, 2019. fda.gov
- Jun 22, 2016: Form 483 to Jajco, Inc., published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Oct 24, 2018 to Oct 29, 2018: 2 observations
- Firm on the cover
- Jajco, Inc. DBA Anchor Drugs Pharmacy, 161 s Spruce Ave, South San Francisco, CA 94080-4517
- FEI number
- 3012327563
- Establishment type on the cover
- Producer of Non-Sterile Drug Products
- FDA district office on the cover
- 1431 Harbor Bay Parkway Alameda, CA 94502-7070
- Matched to this page by
- FEI number on the cover; linked from Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
You produced hazardous drugs without providing adequate cleaning of work surfaces and cleaning of utensils to prevent cross-contamination.
Specifically ,
Your firm's cleaning of utensils, equipment, and work surfaces is inadequate. Your firm uses <Redacted B4> to mix drug substance including testosterone and estradiol. This type of glassware is cleaned in a dishwasher using store bought detergent. Your firm also uses dish soap and lint free wipes to clean the encapsulation equipment and <Redacted B4> our firm does not use dedicated equipment for hazardous diugs and your cleaning process is inadequate to prevent cross-contamination.
Observation 2
Non-microbial contamination was observed in your production area.
Specifically,
Linked 483s whose text is not shown
- Jun 22, 2016: FDA document 98830: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones. Board file.
What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- California State Board of Pharmacy license file
- California State Board of Pharmacy disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.